Story thread · 2 reports / 2 sources
Cellares and Ori Biotech’s new cell therapy manufacturing contracts
endpts.com · 3h
Plus more from Reckitt, Astellas and Hovione. Cellares’ first Asian partnership: The manufacturer has inked a new partnership with Taiwanese company GenomeFrontier Therapeutics, under which Cellares will evaluate manufacturing GenomeFrontier’s CAR-T ...
First report: Cellares and GenomeFrontier Therapeutics Partner to Advance Automated Manufacturing of GF-CART01 — genengnews.com, 1d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.